Bausch Health completes DURECT acquisition for $63 million

September 11, 2025 8:35 AM EDT Send to a Friend
Bausch Health Companies Inc. (NYSE: BHC) completed its acquisition of DURECT Corporation (NASDAQ: DRRX) for $1.75 per share in cash ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login